May 17, 2018
The year 2016 marked the transition in an era of neuro-oncology
from histologic-based diagnoses of primary brain tumors to a
molecular and genetic classification system. Drs. Jorg Dietrich
(neuro-oncology) and Brian Nahed (neurosurgery) of Massachusetts
General Hospital discuss what the reclassification of primary glial
neoplasms means for their patients.
Produced by James E. Siegler. Music by Lee Rosevere, Ian
Sutherland, and Lovira. Voiceover by Erika Mejia. BrainWaves'
podcasts and online content are intended for medical education only
and should not be used for clinical decision making.
- Schiff D. Low-grade Gliomas. Continuum (Minneap Minn).
- Wen PY and Huse JT. 2016 World Health Organization
Classification of Central Nervous System Tumors. Continuum
(Minneap Minn). 2017;23:1531-1547.
- McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K,
Burger PC, Olivi A, Brem H and Quinones-Hinojosa A. Extent of
surgical resection is independently associated with survival in
patients with hemispheric infiltrating low-grade gliomas.
Neurosurgery. 2008;63:700-7; author reply 707-8.
- Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S,
Tihan T, Vandenberg S, McDermott MW and Berger MS. Role of extent
of resection in the long-term outcome of low-grade hemispheric
gliomas. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 2008;26:1338-45.
- Shaw EG, Wang M, Coons SW, Brachman DG, Buckner JC, Stelzer KJ,
Barger GR, Brown PD, Gilbert MR and Mehta MP. Randomized trial of
radiation therapy plus procarbazine, lomustine, and vincristine
chemotherapy for supratentorial adult low-grade glioma: initial
results of RTOG 9802. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology.